This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Naing A , Cohen R , Dy GK , Hong DS , Dyster L , Hangauer DG , Kwan R , Fetterly G , Kurzrock R , Adjei AA
A phase I trial of KX2-391, a novel non-ATP competitive substrate-pocket- directed SRC inhibitor, in patients with advanced malignancies
Investigational New Drugs. 2013 Aug;31(4) :967-973
NotesNaing, Aung Cohen, Roger Dy, Grace K. Hong, David S. Dyster, Lyn Hangauer, David G. Kwan, Rudolf Fetterly, Gerald Kurzrock, Razelle Adjei, Alex A.